Introducing Dream Lab Notes: a public notebook for science and development

A place for useful working knowledge

Dream Lab Notes is the public notebook of The Dream Lab Innovations. It is for researchers asking biological questions and developers working with biological data. The aim is useful context: how to choose a tool, how a search is interpreted, what to record when a workflow fails, and what would make an evaluation reproducible.

This launch opens a publication. It does not announce a new product release, a measured performance gain, or a reviewed research finding. The first entries are editorial guidance and an evaluation plan, not experimental validation.

Three kinds of entry

• Updates explain a real change, its scope, and what a reader needs to do differently. A product announcement should link to the current product page rather than leave an old price or access limit in circulation.
• Lab notes keep questions, proposed methods, observations, and limitations together. A plan will be labelled as a plan. If an experiment has not been run, there is no result to report.
• Practical guides help a reader complete a task, including the points at which a tool is the wrong choice. They are not promises that every workflow will succeed.

You can start with our guide to choosing RBAi, RBAi Scholar, or MCP Cloud, then read the biomedical-search evaluation checklist. The checklist describes what to prepare before a benchmark; it does not report one.

What makes a claim publishable

Useful technical writing separates documentation from observation. A documented feature tells you what a service is intended to do. A test report needs the actual input, environment, date, method, and output. A scientific conclusion needs evidence beyond a search result or a fluent answer.

For this notebook, that means:

1. Link the source of a product behavior or methodological claim.
2. State whether a passage is guidance, a proposed test, or an observation from an executed test.
3. Preserve the important limits: abstract-only evidence, incomplete coverage, uncertain relevance, or an unavailable source version.
4. Record a substantive correction with a date instead of silently changing the meaning of a published claim.

The byline on these opening entries is The Dream Lab Innovations. It does not imply authorship or scientific review by a named member of the company. Individual authorship or review should be attributed only when it actually occurs.

What is available today

Our product overview is the place to check the current product presentation. RBAi Scholar supports biomedical literature discovery, and its search guide explains the important differences between semantic queries, keyword queries, and quoted requirements. MCP Cloud is the developer-facing route to managed biological-data tools. RBAi itself is an alpha research workspace with access by request through Contact.

These are different starting points, not interchangeable guarantees. Notes will explain decisions around them without substituting for current documentation, primary literature, or validation of a research workflow.

Follow, question, or correct a note

The first version has an RSS feed. Add it to your own feed reader to follow published entries. Email delivery is deferred until a real delivery provider and consent flow are in place; there is no newsletter sign-up in this version.

Every article has links for feedback and experiment suggestions. A useful message includes the article URL, the specific claim or question, and a source or reproducible example. For help choosing a workflow, use Contact. Please leave out API keys, confidential datasets, and identifiable patient information.

The goal is a notebook that helps you ask a better question and keep the evidence attached to the answer.